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ABSTRACT During routine screening for Burkholderia pseudomallei from water wells
in northern Australia in areas where it is endemic, Gram-negative bacteria (strains
MSMB43T, MSMB121, and MSMB122) with a similar morphology and biochemical
pattern to B. pseudomallei and B. thailandensis were coisolated with B. pseudomallei
on Ashdown’s selective agar. To determine the exact taxonomic position of these
strains and to distinguish them from B. pseudomallei and B. thailandensis, they were
subjected to a series of phenotypic and molecular analyses. Biochemical and fatty
acid methyl ester analysis was unable to distinguish B. humptydooensis sp. nov. from
closely related species. With matrix-assisted laser desorption ionization–time of flight
analysis, all isolates grouped together in a cluster separate from other Burkholderia
spp. 16S rRNA and recA sequence analyses demonstrated phylogenetic placement
for B. humptydooensis sp. nov. in a novel clade within the B. pseudomallei group.
Multilocus sequence typing (MLST) analysis of the three isolates in comparison with
MLST data from 3,340 B. pseudomallei strains and related taxa revealed a new se-
quence type (ST318). Genome-to-genome distance calculations and the average nu-
cleotide identity of all isolates to both B. thailandensis and B. pseudomallei, based on
whole-genome sequences, also confirmed B. humptydooensis sp. nov. as a novel
Burkholderia species within the B. pseudomallei complex. Molecular analyses clearly
demonstrated that strains MSMB43T, MSMB121, and MSMB122 belong to a novel
Burkholderia species for which the name Burkholderia humptydooensis sp. nov. is pro-
posed, with the type strain MSMB43T (American Type Culture Collection BAA-2767;
Belgian Co-ordinated Collections of Microorganisms LMG 29471; DDBJ accession
numbers CP013380 to CP013382).
IMPORTANCE Burkholderia pseudomallei is a soil-dwelling bacterium and the caus-
ative agent of melioidosis. The genus Burkholderia consists of a diverse group of
species, with the closest relatives of B. pseudomallei referred to as the B. pseu-
domallei complex. A proposed novel species, B. humptydooensis sp. nov., was iso-
lated from a bore water sample from the Northern Territory in Australia. B.
humptydooensis sp. nov. is phylogenetically distinct from B. pseudomallei and
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other members of the B. pseudomallei complex, making it the fifth member of
this important group of bacteria.
KEYWORDS Burkholderia humptydooensis sp. nov., Burkholderia pseudomallei
complex, MSMB43T
Burkholderia species are abundant and occupy diverse ecological niches, includingsoil, plants, animals, and humans. Probably the most diverse and environmentally
adaptable plant-associated bacteria also belong to the genus Burkholderia (1). Many
species of Burkholderia have been described since the discovery of B. cepacia by W. H.
Burkholder in 1949 as the cause of onion rot (2); this species was later recognized as a
human pathogen. Currently, there are more than 90 identified species in this genus (3,
4). There has been a proposal to divide the species into two genera, one of which would
retain the Burkholderia name and the other which would be Paraburkholderia gen. nov.
(5). At least 20 closely related species belong to the Burkholderia cepacia complex, with
many of these soil-dwelling species considered opportunistic pathogens for immuno-
compromised individuals and other species considered to have both mutualistic and
pathogenic roles in plants (6).
Notably, there are two Burkholderia species that can cause severe human and animal
diseases: B. pseudomallei and B. mallei, the causative agents of melioidosis and glanders,
respectively. B. pseudomallei is a major cause of community-acquired sepsis in north-
east Thailand and northern Australia (7). Due to the concerns of their potential use as
weapons of mass destruction, federal health agencies in the United States have recently
classified these species as Tier 1 (top tier) disease agents (8). It has been well established
that B. mallei is a clone of B. pseudomallei that became a host-adapted pathogen in
equines, resulting in a massive genome reduction (9). Genetically, both B. pseudomallei
and B. mallei are members of the B. pseudomallei phylogenetic group or complex (10).
Three additional closely related species have been identified so far in this group: B.
thailandensis (11), B. oklahomensis (12), and a newly identified B. thailandensis-like
species (13, 14). These closely related species are soil saprophytes and are considered
nonpathogenic, although a few strains of B. thailandensis and B. oklahomensis have
been described as causing clinical infection in humans (12, 15).
RESULTS AND DISCUSSION
Bacterial growth and characteristics. As described previously (14), B. humpty-
dooensis sp. nov. MSMB43T did not grow when incubated at temperatures higher than
42°C and also produced little or no gas from nitrate. On Columbia blood agar, smooth
and creamy white colonies were observed after 24 h, whereas red, convex, and
small (1- to 2-mm) colonies were observed on MacConkey medium after 48 h. Dry
and wrinkled colonies were observed on Ashdown’s agar after 72 h of growth (Fig.
1), similar to the appearance of B. pseudomallei, while slimy, confluent, honey-like
growth appeared on Standard I medium after 48 h (Fig. 1). Variations in colony
morphology may exist within MSMB43T, as the morphology of MSMB43T on Ash-
down’s agar was previously reported as smooth and round colonies (16). Bacterial
growth was visible on all media after incubation at 25 to 42°C for at least 24 h, with
the best growth observed on Columbia blood agar. No growth was observed at 8°C
and 45°C. The optimal temperatures for growth were between 28 and 37°C aero-
bically. All strains showed Gram-negative bipolar staining, appearing as rods of 2 to
3 m in length and 0.4 to 0.8 m in diameter. All strains were motile in semisolid
media. Biochemical differentiation of B. humptydooensis sp. nov. from B. pseudomallei
and B. thailandensis was possible by screening for the presence of tryptophan, esculin,
or the assimilation of arabinose (to distinguish from B. pseudomallei) and the assimi-
lation of maltose (to differentiate from B. thailandensis) (Table 1). All strains were
positive for nitrate, gelatin, glucose, mannose, mannitol, N-acetylglucosamine, gluco-
nate, caprate, adipate, malate, citrate, and phenylacetate. All strains were negative for
glucose (acidification) and urea (Table 1).
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Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-
TOF MS) of the three isolates showed a cluster with other members of the B. pseu-
domallei complex (see Fig. S1 in the supplemental material). Fatty acid methyl ester
analysis was unable to distinguish among the fatty acid profiles from the three B.
humptydooensis sp. nov. strains and the closely related species (five B. thailandensis, two
B. oklahomensis, and three B. ubonensis strains) (Fig. S2).
Antimicrobial susceptibility and virulence screening. Based on the CLSI break-
points for B. pseudomallei, all strains were determined to be susceptible in vitro to
ceftazidime, imipenem, trimethoprim-sulfamethoxazole, and doxycycline, whereas re-
TABLE 1 Phenotypic characteristics of B. humptydooensis sp. nov. and closely related species within the B. pseudomallei group
Biochemical reaction





B. humptydooensis sp. nov.
MSMB43T
B. humptydooensis sp. nov.
MSMB121
B. humptydooensis sp. nov.
MSMB122
Tryptophan     
Arginine     
Esculin     
PNPG     
Arabinose assimilation     
Maltose assimilation     
aData for B. pseudomallei K96243 were obtained from Wuthiekanun et al. (29).
FIG 1 Colony morphology of B. humptydooensis sp. nov. MSMB43T. Cultures were grown on Ashdown’s
agar (a) or on Standard I nutrient agar (b).
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sistance to amoxicillin-clavulanic acid was observed (Table 2). The antimicrobial sus-
ceptibility pattern of B. humptydooensis sp. nov. generally resembled that of B. pseu-
domallei (17–20). No significant differences were observed either among the three
strains or between the two different susceptibility testing methods. As the maximum
concentration of aminoglycosides in the microtiter plates was 32 mg/liter, high-level
streptomycin resistance but low-level gentamicin resistance were confirmed using the
Etest method (data not shown).
Neither B. humptydooensis sp. nov. nor B. thailandensis caused mortality in any mice
when delivered via the subcutaneous (s.c.) route, nor did any mice show outward signs
of illness. In comparison, s.c. infections of fully virulent B. pseudomallei results in 50%
mortality within 10 days at a dose of 103 CFU (21). It remains unknown if the inhalation
route increases the pathogenicity of species tested in the same way as B. thailandensis
E264T, which can cause high mortality in mice at doses of 104 to 106 CFU when
delivered as an aerosol (22–24).
Genetic and genomic comparative analyses. Four rRNA operons are present on
the MSMB43T chromosomes, of which two unique versions were found (AQ610_12930/
AQ610_01425 and AQ610_21350/AQ610_02540). The genomes of strains MSMB43T,
MSMB121, and MSMB122 each consisted of two chromosomes (Table 3). These two
copies of the 16S rRNA genes were different, which led to ambiguities in conventional
sequencing (Fig. S3). The 16S rRNA gene sequence similarities of B. humptydooensis sp.
nov. to other members of the B. pseudomallei complex (B. thailandensis, B. mallei, and
B. oklahomensis) were 99%. Phylogenetic reconstruction of 16S rRNA and recA se-
quences confirmed genetic proximity to the B. pseudomallei complex but also deter-
mined that all B. humptydooensis sp. nov. strains formed their own group within this
complex (Fig. S3 and S4).
All three B. humptydooensis sp. nov. strains, MSMB43T, MSMB121, and MSMB122, are
sequence type 318 (ST318), and there are no other representatives of this ST. Overall,
phylogenetic analysis using multilocus sequence typing (MLST) data supports the




Amoxicillin-clavulanic acida 32/16 32/16 32/16
Ceftazidime 4 2 4
Imipenem 0.5 0.5 0.5
Rifampin 8 8 8
Chloramphenicol 8 4 4
Trimethoprim-sulfamethoxazole 0.5/9.5 0.25/4.75 0.25/4.75
Streptomycin 32 32 32
Gentamicin 32 32 32
Doxycycline 1 1 1
Tigecycline 2 4 4
Ciprofloxacin 0.5 1 1
Levofloxacin 0.5 1 1
aResistance was observed, based upon the CLSI breakpoints of B. pseudomallei.
TABLE 3 Whole-genome dataa for B. pseudomallei group organisms
Species and strain GC content (%) Genome size (Mb) No. of CDSc
B. humptydooensis sp. nov. MSMB43T 67.1 7.3b 6,324
B. humptydooensis sp. nov. MSMB121 67.5 6.7 5,795
B. humptydooensis sp. nov. MSMB122 67.5 6.8 5,845
B. thailandensis E264T 67.6 6.7 5,652
B. oklahomensis C6786T 66.9 7.1 6,097
B. pseudomallei K96243 68.1 7.2 5,948
B. mallei ATCC 23344T 68.5 5.8 5,006
aTwo chromosomes are present in all genomes shown.
bOne plasmid present.
cCDS, coding DNA sequences.
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separation of B. humptydooensis sp. nov. from the other B. pseudomallei complex
members, as described previously (14).
The PacBio sequencing resulted in one finished assembly (for MSMB43T) and one
mostly finished assembly with 4 contigs (MSMB122) (Table 3). The MSMB43T genome
had one circular contig 305 kb long that appears to be a plasmid; this same sequence
is also present in the previously completed genome of Burkholderia sp. MSMB43T
(alternately known as 2002721687 [BioProject no. PRJNA239255]). A comparative
genomics approach using large-scale BLAST score ratios (LS-BSR) (25) demonstrated
that a large (35-kb) stretch of the B. pseudomallei K96243 genome (UniProt gene
names BPSS1165 [accession number Q63L43] to BPSS1184 [accession number Q63L24])
on chromosome 2 is highly conserved (98% identity) in the plasmid sequence,
suggesting a shared origin for these regions. The core genome phylogeny demon-
strated the position of B. humptydooensis sp. nov. in relation to other clades in the B.
pseudomallei complex and confirms the results from other methods (Fig. 2).
Among the three tested B. humptydooensis sp. nov. genomes, the calculated
genome-to-genome distance calculation (GGDC) and average nucleotide identity (ANI)
values were in the range of 93 to 99% and 98 to 99%, respectively (Table 4). The high
GGDC and ANI values indicate that all of these tested strains belong to a single species,
including the proposed B. humptydooensis sp. nov. type strain MSMB43T. As expected
from whole-genome sequencing (WGS) analyses, strain MSMB43T had a slightly lower
GGDC similarity (93%) than the other two B. humptydooensis sp. nov. strains, which
were approximately 97% similar. Further GGDC analysis (Table 4) determined that the
similarities of all B. humptydooensis sp. nov. strains to all other tested Burkholderia
species in the B. pseudomallei complex were less than 70%, with the highest detected
similarity being between B. humptydooensis sp. nov. and B. thailandensis (51.1% [
3.2%]) (mean  confidence interval [CI]). This confirmed that the three tested strains are
not B. thailandensis but rather a distinct species. The GGDC similarity between B. mallei
and B. pseudomallei was 92.5%, which confirmed previous conventional DNA-DNA
hybridization (DDH) results and demonstrated that, from a strict taxonomic point of
view, they belong to a single species (9).
In conclusion, we have utilized comprehensive genotyping techniques, including
16S rRNA, recA, MLST, and whole-genome-based GGDC, to further support the exis-
tence of a new species that is distinct but genetically related to the four members of
the B. pseudomallei complex (B. pseudomallei, B. mallei, B. thailandensis, and B. oklaho-
mensis). These analyses confirm the speciation of B. humptydooensis sp. nov., a soil
bacterial saprophyte found in the Northern Territory of Australia, where melioidosis is
highly endemic. The addition of B. humptydooensis sp. nov. as a new member of the B.
pseudomallei complex will benefit evolutionary studies of B. pseudomallei, the serious
bacterial pathogen that shares a similar ecological niche with this new species.
FIG 2 Core genome phylogeny of B. humptydooensis sp. nov. SNPs from the comparison of four B.
humptydooensis sp. nov. genomes and representatives of the other closely related species were used to
reconstruct the phylogenetic relationships. Genomes from this study are shown in bold and assembly
numbers are provided inside parentheses. Numbers at nodes indicate bootstrap support values. Col-
lapsed nodes are shown in gray.
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TAXONOMY
Burkholderia humptydooensis sp. nov. (hump.ty.doo.en’sis. L. gen. adj. humptydooen-
sis, pertaining to Humpty Doo, a small town in Northern Territory of Australia, where the
first member of this species was isolated).
Bacilli, 0.4 to 0.8 m in diameter and 2 to 3 m in length, arranged individually or
in irregular clusters. The organism is Gram negative with bipolar staining, motile, and
non-spore forming. Growth is observed in a temperature range of 25 to 42°C within 24
to 48 h on various standard solid media. Within 24 h, small colonies (0.5 to 1 mm) are
formed on nonselective media (Columbia blood and Standard I) and after 48 h also on
selective media (Ashdown’s, MacConkey). Best growth occurs at 28 to 37°C after 24
h. Colonies become confluent and honey-like in appearance on glycerol-containing
medium (Standard I) after 48 h. On Ashdown’s selective agar, highly wrinkled purple
colonies are observed at 48 h, thus resembling the growth of B. pseudomallei.
Assimilation (API 20NE) was found for D-glucose, L-arabinose, D-mannose, D-mannitol,
N-acetylglucosamine, potassium gluconate, capric acid, adipic acid, malic acid, trisodium
citrate, and phenylacetic acid, while results were negative for D-maltose. Esculin and gelatin
are hydrolyzed. Variable reactions with L-arginine and 4-nitrophenyl- D-galactopyranoside
(PNPG).
Positive (API ZYM) for alkaline phosphatase, esterase, esterase lipase, lipase, leucine
arylamidase, acidic phosphatase, and naphthol-AS-BI-phosphohydrolase. Enzymes absent
on API ZYM are valine arylamidase, cystin arylamidase, trypsin, -chymotrypsin, - and
-galactosidase, -glucuronidase, - and -glucosidase, N-acetyl--glucosaminidase,
-mannosidase, and -frucosidase. This species is aerobic, catalase and oxidase positive,
and urease and indole negative. Nitrate and nitrite are reduced (with no gas formation from
nitrite) and no production of H2S.
B. humptydooensis sp. nov. strains are resistant to aminoglycosides and amoxicillin-
clavulanic acid but susceptible to trimethoprim-sulfmethoxazole, doxycycline, imi-
penem, and ceftazidime. All B. humptydooensis sp. nov. strains are seroreactive with
sera from melioidosis patients who were infected with B. pseudomallei serotype B
strains. All strains produced O-antigen ladder type B2, except that strain MSMB43T
produced a novel O-antigen ladder type (26). The type strain, MSMB43T, has been
previously referred to as B. thailandensis-like species in multiple studies (13, 14).
MSMB43T was isolated in 1995 from an automated water well (bore) in Humpty Doo,
Australia. B. humptydooensis sp. nov., like B. thailandensis, is nonvirulent in mice. In
addition, MSMB43T is known to produce thailanstatins, which possess antiproliferative
activities in representative human cancer cell lines (27). The type strain MSMB43T has
been deposited in the American Type Culture Collection as BAA-2767 and the Belgian
Co-ordinated Collections of Microorganisms as LMG 29471.
MATERIALS AND METHODS
Strain isolation. Strain MSMB43T was isolated from a water sample from an automated water bore
(well) collected in 1995 and examined for B. pseudomallei in the Northern Territory (NT) of Australia. This
strain was initially thought to be B. thailandensis due to its ability to assimilate arabinose as a sole carbon
source, which is a trait used to discriminate B. thailandensis from B. pseudomallei (arabinose negative)
(14). The bore from which MSMB43T was discovered is located in Humpty Doo, a region of rural
properties outside the capital of the NT, Darwin. The Top End of the NT has a high incidence rate of
melioidosis (28). In fact, the water sample from which MSMB43T was recovered also yielded B. pseu-
domallei. An additional two strains (MSMB121 and MSMB122) were both isolated in 2007 from a single
separate bore water sample within the NT collected approximately 950 km south of the territory capital,
Darwin, resulting in a 910-km separation between the two sample sites of MSMB121/MSMB122 and
MSMB43T. To date, the proposed B. humptydooensis sp. nov. has not been identified outside the NT, and
it has not been isolated from any clinical specimens from patients within the NT.
The specific epithet “humptydooensis” given to this new species was adopted from the location
name Humpty Doo, where this new species was first discovered.
Bacterial growth and characteristics. All three strains were grown at temperatures of 8, 25, 37, 42,
and 45°C for 24, 48, 72, and 144 h on Columbia blood agar, MacConkey agar, Ashdown’s selective agar,
and Standard I nutrient agar with and without supplementary CO2. Cell morphology was examined using
a Zeiss light microscope at 1,000 magnification with cells grown for 2 days at 37°C. Biochemical data
were obtained for all three strains of B. humptydooensis sp. nov. (MSMB43T, MSMB121, and MSMB122)
Burkholderia humptydooensis sp. nov. Applied and Environmental Microbiology
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and compared to data for strains of B. pseudomallei (K96243) (29) and B. thailandensis (E264T) by using
the API ONE and API Zym systems (bioMérieux) according to the manufacturer’s instructions.
MALDI-TOF MS and fatty acid methyl ester analysis was performed for all three B. humptydooensis sp.
nov strains (see the text in the supplemental material for a detailed description of these methods).
Antimicrobial susceptibility screening. MICs were determined by the broth microdilution method
using commercially available CE-certified Micronaut-S 96-well microtiter plates (Merlin, Bornheim-Hersel,
Germany) containing 2-fold serial dilutions of the following antibiotics: amoxicillin-clavulanic acid (0.5 to
64/0.25 to 32 mg/liter), ceftazidime (0.5 to 64 mg/liter), imipenem (0.25 to 32 mg/liter), rifampin (0.0625
to 8 mg/liter), chloramphenicol (0.5 to 64 mg/liter), trimethoprim-sulfamethoxazole (0.25 to 32/4.75 to
608 mg/liter), streptomycin (0.25 to 32 mg/liter), gentamicin (0.25 to 32 mg/liter), doxycycline (0.25 to 32
mg/liter), tigecycline (0.03125 to 4 mg/liter), ciprofloxacin (0.03125 to 4 mg/liter), and levofloxacin
(0.0625 to 4 mg/liter). One well without antibiotic was used as a growth control. All plates containing the
lyophilized antimicrobial substances were stored at room temperature until use.
Testing conditions were in accordance with the current Clinical and Laboratory Standards Institute
(CLSI) recommendations for B. pseudomallei (30). Single colonies of MSMB43T, MSMB121, and MSMB122
were picked from agar plates and inoculated in physiological saline (0.85% NaCl) until the turbidity
matched that of a 0.5 McFarland standard. The suspension was diluted 221-fold in cation-adjusted
Mueller-Hinton II broth (catalog number 297701; Becton Dickinson). After incubation for 24 h at 37°C in
a 5% CO2 atmosphere, bacterial growth was verified photometrically at a wavelength of 620 nm using
a commercial photometer (Merlin, Bornheim-Hersel, Germany), and each strain was tested in triplicate.
Additionally, a gradient strip method (Etest; bioMérieux) was applied to investigate a broader range of
antibiotic concentrations.
Virulence testing in mouse models. The pathogenic potential of B. humptydooensis sp. nov.
MSMB43T was investigated in a BALB/c mouse model and compared to the pathogenic potential of B.
thailandensis (type strain E264T). Live cultures were grown to logarithmic phase (optical density at 600
nm, 1.0) in Luria-Bertani (LB) broth as previously described (22). Sterile 1 phosphate-buffered saline
(PBS) was used to wash cells twice before making dilutions for injecting mice. Viability counts of the final
inocula were made on LB agar plates. Six- to 8-week-old female BALB/c mice in treatment groups of 5
mice per cage were used. Food and water were provided ad libitum. All mice in a single cage received
the same infectious dose (B. humptydooensis sp. nov.: 1.05  104, 105, or 106 CFU; B. thailandensis: 3.4 
104, 105, or 106 CFU) via a single s.c. injection in the scruff of the neck. Mice were monitored daily for
health status. All mice were euthanized on day 21 postinjection. This work was conducted under approved
protocols from the NAU IACUC (protocol 14-011) and DOD ACURO (HDTRA1-12-C-0066_Wagner).
16S rRNA and recA gene analysis. 16S rRNA and recA gene sequencing analyses were performed
on three B. humptydooensis sp. nov. strains: MSMB43T, MSMB121, and MSMB122, as previously described
(11, 31). From whole-genome analysis of strain MSMB43T using the SSU-ALIGN program (32), we
investigated the number of rRNA operons present. Phylogenetic reconstruction of 16S rRNA and recA
sequences was conducted using MEGA version 6 (33).
MLST. MLST was performed on all three B. humptydooensis sp. nov. strains as previously described
(9). As of 7 October 2016, a total of 1,439 sequence types had been identified in B. pseudomallei and
closely related species by MLST (http://www.MLST.net). The seven genes that comprise this MLST are ace,
gltB, gmhD, lepA, lipA, narK, and ndh.
Genome assembly and core genome phylogeny. Two genomes (MSMB43T and MSMB122) were
sequenced on the PacBio platform. Two other genomes that group with B. humptydooensis sp.
nov. are present in GenBank and consist of strains MSMB121 and MSMB43T (which is the same type
strain used in this study but is listed with an alternative BioProject strain identifier, 2002721687
[BioProject no. PRJNA239255]) (34, 35) with GenBank assembly accession numbers GCA_000385525 and
GCA_000959325, respectively. A comparative genomics approach using LS-BSR (25) was also performed
with the B. pseudomallei genome strain K96243 (BPSS1165 to BPSS1184).
For the core genome phylogeny, genomes were aligned against B. pseudomallei K96243 by using
NUCmer (36). The reference genome was also aligned against itself to identify duplicated regions, which
were masked from subsequent analyses; the NASP pipeline was used to wrap these methods (http://
tgennorth.github.io/NASP/). A phylogeny was inferred by using RAxML v8 (37) on a large set (n 
331,000) of concatenated single nucleotide polymorphisms (SNPs) using a time-reversible model incor-
porating the Lewis ascertainment bias correction.
Genome-to-genome distance calculations. DDH is the current gold standard for bacterial species
delineation. DDH is necessary for the description of a new species within a taxon when strains share more
than 98.65% 16S rRNA gene sequence similarity (38). If DNA-DNA relatedness between two strains is less
than 70%, the two strains are considered different species. However, DDH is laborious and difficult to
standardize, and interlaboratory reproducibility is relatively low. DDH was previously performed on
MSMB43T and showed a relative binding ratio of 91% with B. thailandensis (ATCC 700388) with a
divergence of 4% (14). Because of the drawbacks of conventional DDH and the rapid progress in genome
sequencing techniques, various in silico algorithms for calculating genome-to-genome similarities or
distances have been developed. In addition to the commonly used ANI method (39), recently a highly
reliable estimator for the relatedness of genomes was developed by Jan P. Meier-Kolthoff and colleagues
(40). GGDC produces digital DDH values that correlate well with values obtained by conventional DDH,
which is of utmost importance for compatibility with the current species concept and also provides
confidence interval estimation. DDH values were calculated using formula 2 in GGDC; this formula
summed the identities found in high-scoring segment pairs (HSP) and then divided them by the overall
HSP length. The GGDC service is available from the German Collection of Microorganisms and Cell
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Cultures home page (http://ggdc.dsmz.de/distcalc2.php). PacBio assemblies were used to determine the
distances among B. humptydooensis sp. nov. and other closely related species. The genomes were
subjected to GGDC analysis and compared to the available genome sequences of B. pseudomallei, B.
mallei, B. oklahomensis, and B. thailandensis reference strains (K96243, ATCC 23344T, C6786T, and E264T,
respectively). For comparison, the ANI values were also calculated for all reference sequences by using
JSpecies (41); the authors of JSpecies determined that ANI values of 	95% indicate separate species.
Accession number(s). GenBank accession numbers for the 16S rRNA gene sequences of B. hump-
tydooensis sp. nov. strains MSMB121 and MSMB122 are KF378608 and KF378609, respectively. The
complete whole-genome sequence of the strain MSMB121 was published under GenBank accession
numbers CP004095 and CP004096 (34, 35). The assembly for MSMB43T was published under GenBank
assembly number GCA_001513745 and that for MSMB122 under SRA numbers SRR1956040 and
LNPD00000000.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
AEM.02802-16.
TEXT S1, PDF file, 0.44 MB.
ACKNOWLEDGMENTS
We declare no conflicts of interest.
The findings and conclusions in this report are those of the authors and do not
necessarily represent the official position of the Centers for Disease Control and
Prevention.
This work was funded by the U.S. Department of Homeland Security (HSHQDC-10-
C-00135 and HSHQDC-10-C-00149), the Defense Threat Reduction Agency (HDTRA1-
12-C-0066 and HSHQDC-10-C-00149), the Australian National Health and Medical Re-
search Council, and the Australian Research Council.
REFERENCES
1. Compant S, Nowak J, Coenye T, Clement C, Barka EA. 2008. Diversity and
occurrence of Burkholderia spp. in the natural environment. FEMS Microbiol
Rev 32:607–626. https://doi.org/10.1111/j.1574-6976.2008.00113.x.
2. Burkholder WH. 1950. Sour skin, a bacterial rot of onion bulbs. Phyto-
pathology 40:115–117.
3. Vial L, Chapalain A, Groleau MC, Deziel E. 2011. The various lifestyles of the
Burkholderia cepacia complex species: a tribute to adaptation. Environ
Microbiol 13:1–12. https://doi.org/10.1111/j.1462-2920.2010.02343.x.
4. Gu JY, Zang SG, Sheng XF, He LY, Huang Z, Wang Q. 2015. Burkholderia
susongensis sp. nov., a mineral-weathering bacterium isolated from
weathered rock surface. Int J Syst Evol Microbiol 65:1031–1037. https://
doi.org/10.1099/ijs.0.000059.
5. Sawana A, Adeolu M, Gupta RS. 2014. Molecular signatures and phylog-
enomic analysis of the genus Burkholderia: proposal for division of this
genus into the emended genus Burkholderia containing pathogenic
organisms and a new genus Paraburkholderia gen. nov. harboring en-
vironmental species. Front Genet 5:429. https://doi.org/10.3389/
fgene.2014.00429.
6. De Smet B, Mayo M, Peeters C, Zlosnik JE, Spilker T, Hird TJ, LiPuma JJ,
Kidd TJ, Kaestli M, Ginther JL, Wagner DM, Keim P, Bell SC, Jacobs JA,
Currie BJ, Vandamme P. 2015. Burkholderia stagnalis sp. nov. and Burk-
holderia territorii sp. nov., two novel Burkholderia cepacia complex
species from environmental and human sources. Int J Syst Evol Microbiol
65:2265–2271. https://doi.org/10.1099/ijs.0.000251.
7. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology,
and management. Clin Microbiol Rev 18:383– 416. https://doi.org/
10.1128/CMR.18.2.383-416.2005.
8. Butler D. 2012. Infectious disease viral research faces clampdown. Nature
490:456. https://doi.org/10.1038/490456a.
9. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R,
Spratt BG. 2003. Multilocus sequence typing and evolutionary relation-
ships among the causative agents of melioidosis and glanders, Burk-
holderia pseudomallei and Burkholderia mallei. J Clin Microbiol 41:
2068 –2079. https://doi.org/10.1128/JCM.41.5.2068-2079.2003.
10. Sahl JW, Vazquez AJ, Hall CM, Busch JD, Tuanyok A, Mayo M, Schupp JM,
Lummis M, Pearson T, Shippy K, Colman RE, Allender CJ, Theobald V,
Sarovich DS, Price EP, Hutcheson A, Korlach J, LiPuma JJ, Ladner J, Lovett
S, Koroleva G, Palacios G, Limmathurotsakul D, Wuthiekanun V, Wong-
suwan G, Currie BJ, Keim P, Wagner DM. 2016. The effects of signal
erosion and core genome reduction on the identification of diagnostic
markers. mBio 7:e00846-16. https://doi.org/10.1128/mBio.00846-16.
11. Brett PJ, Deshazer D, Woods DE. 1997. Characterization of Burkholderia
pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol In-
fect 118:137–148. https://doi.org/10.1017/S095026889600739X.
12. Glass MB, Steigerwalt AG, Jordan JG, Wilkins PP, Gee JE. 2006. Burkhold-
eria oklahomensis sp. nov., a Burkholderia pseudomallei-like species
formerly known as the Oklahoma strain of Pseudomonas pseudomallei.
Int J Syst Evol Microbiol 56:2171–2176. https://doi.org/10.1099/
ijs.0.63991-0.
13. Currie BJ. 2015. Melioidosis: evolving concepts in epidemiology, patho-
genesis, and treatment. Semin Respir Crit Care Med 36:111–125. https://
doi.org/10.1055/s-0034-1398389.
14. Gee JE, Glass MB, Novak RT, Gal D, Mayo MJ, Steigerwalt AG, Wilkins PP,
Currie BJ. 2008. Recovery of a Burkholderia thailandensis-like isolate
from an Australian water source. BMC Microbiol 8:54. https://doi.org/
10.1186/1471-2180-8-54.
15. Glass MB, Gee JE, Steigerwalt AG, Cavuoti D, Barton T, Hardy RD, Godoy
D, Spratt BG, Clark TA, Wilkins PP. 2006. Pneumonia and septicemia
caused by Burkholderia thailandensis in the United States. J Clin Micro-
biol 44:4601– 4604. https://doi.org/10.1128/JCM.01585-06.
16. Ginther JL, Mayo M, Warrington SD, Kaestli M, Mullins T, Wagner DM, Currie
BJ, Tuanyok A, Keim P. 2015. Identification of Burkholderia pseudomallei
near-neighbor species in the Northern Territory of Australia. PLoS Negl Trop
Dis 9:e0003892. https://doi.org/10.1371/journal.pntd.0003892.
17. Ahmad N, Hashim R, Mohd Noor A. 2013. The in vitro antibiotic suscep-
tibility of Malaysian isolates of Burkholderia pseudomallei. Int J Microbiol
2013:121845. https://doi.org/10.1155/2013/121845.
18. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. 2004.
Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and
Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother
54:1134 –1138. https://doi.org/10.1093/jac/dkh471.
19. Trunck LA, Propst KL, Wuthiekanun V, Tuanyok A, Beckstrom-
Sternberg SM, Beckstrom-Sternberg JS, Peacock SJ, Keim P, Dow SW,
Schweizer HP. 2009. Molecular basis of rare aminoglycoside suscep-
tibility and pathogenesis of Burkholderia pseudomallei clinical iso-
Burkholderia humptydooensis sp. nov. Applied and Environmental Microbiology
March 2017 Volume 83 Issue 5 e02802-16 aem.asm.org 9
lates from Thailand. PLoS Negl Trop Dis 3:e519. https://doi.org/
10.1371/journal.pntd.0000519.
20. Crowe A, McMahon N, Currie BJ, Baird RW. 2014. Current antimicrobial
susceptibility of first-episode melioidosis Burkholderia pseudomallei iso-
lates from the Northern Territory, Australia. Int J Antimicrob Agents
44:160 –162. https://doi.org/10.1016/j.ijantimicag.2014.04.012.
21. Barnes JL, Ketheesan N. 2005. Route of infection in melioidosis. Emerg
Infect Dis 11:638 – 639. https://doi.org/10.3201/eid1104.041051.
22. Morici LA, Heang J, Tate T, Didier PJ, Roy CJ. 2010. Differential suscep-
tibility of inbred mouse strains to Burkholderia thailandensis aerosol
infection. Microb Pathog 48:9 –17. https://doi.org/10.1016/j.micpath
.2009.10.004.
23. West TE, Frevert CW, Liggitt HD, Skerrett SJ. 2008. Inhalation of
Burkholderia thailandensis results in lethal necrotizing pneumonia in
mice: a surrogate model for pneumonic melioidosis. Trans R Soc Trop
Med Hyg 102(Suppl 1):S119 –S126. https://doi.org/10.1016/S0035
-9203(08)70028-2.
24. Wiersinga WJ, de Vos AF, de Beer R, Wieland CW, Roelofs JJ, Woods DE,
van der Poll T. 2008. Inflammation patterns induced by different Burk-
holderia species in mice. Cell Microbiol 10:81– 87. https://doi.org/
10.1111/j.1462-5822.2007.01016.x.
25. Sahl JW, Caporaso JG, Rasko DA, Keim P. 2014. The large-scale blast score
ratio (LS-BSR) pipeline: a method to rapidly compare genetic content
between bacterial genomes. PeerJ 2:e332. https://doi.org/10.7717/
peerj.332.
26. Stone JK, Mayo M, Grasso SA, Ginther JL, Warrington SD, Allender CJ,
Doyle A, Georgia S, Kaestli M, Broomall SM, Karavis MA, Insalaco JM,
Hubbard KS, McNew LA, Gibbons HS, Currie BJ, Keim P, Tuanyok A. 2012.
Detection of Burkholderia pseudomallei O-antigen serotypes in near-
neighbor species. BMC Microbiol 12:250. https://doi.org/10.1186/1471
-2180-12-250.
27. Liu XY, Biswas S, Berg MG, Antapli CM, Xie F, Wang Q, Tang MC, Tang GL,
Zhang LX, Dreyfuss G, Cheng YQ. 2013. Genomics-guided discovery of
thailanstatins A, B, and C as pre-mRNA splicing inhibitors and antipro-
liferative agents from Burkholderia thailandensis MSMB43. J Nat Prod
76:685– 693. https://doi.org/10.1021/np300913h.
28. Parameswaran U, Baird RW, Ward LM, Currie BJ. 2012. Melioidosis at
Royal Darwin Hospital in the big 2009-2010 wet season: comparison
with the preceding 20 years. Med J Austr 196:345–348. https://doi.org/
10.5694/mja11.11170.
29. Wuthiekanun V, Smith MD, Dance DA, Walsh AL, Pitt TL, White NJ. 1996.
Biochemical characteristics of clinical and environmental isolates of
Burkholderia pseudomallei. J Med Microbiol 45:408 – 412. https://
doi.org/10.1099/00222615-45-6-408.
30. Clinical and Laboratory Standards Institute. 2010. Methods for antimi-
crobial dilution and disk susceptibility testing of infrequently isolated or
fastidious bacteria; approved guideline, 2nd ed, vol 30, no. 18. Clinical
and Laboratory Standards Institute, Wayne, PA.
31. Payne GW, Vandamme P, Morgan SH, LiPuma JJ, Coenye T, Weightman
AJ, Jones TH, Mahenthiralingam E. 2005. Development of a recA gene-
based identification approach for the entire Burkholderia genus. Appl
Environ Microbiol 71:3917–3927. https://doi.org/10.1128/AEM.71.7.3917
-3927.2005.
32. Nawrocki EP, Kolbe DL, Eddy SR. 2009. Infernal 1.0: inference of RNA
alignments. Bioinformatics 25:1335–1337. https://doi.org/10.1093/
bioinformatics/btp157.
33. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6:
Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol
30:2725–2729. https://doi.org/10.1093/molbev/mst197.
34. Johnson SL, Bishop-Lilly KA, Ladner JT, Daligault HE, Davenport KW,
Jaissle J, Frey KG, Koroleva GI, Bruce DC, Coyne SR, Broomall SM,
Ketheesan N, Mayo M, Hoffmaster A, Elrod MG, Wuthiekanun V,
Tuanyok A, Norton R, Currie BJ, Wagner DM, Keim P, Li PE, Teshima H,
Gibbons HS, Palacios GF, Rosenzweig CN, Redden CL, Xu Y, Minogue
TD, Chain PS. 2016. Correction for Johnson et al., Complete genome
sequences for 59 Burkholderia isolates, both pathogenic and near
neighbor. Genome Announc 4:e00313-16. https://doi.org/10.1128/
genomeA.00313-16.
35. Johnson SL, Bishop-Lilly KA, Ladner JT, Daligault HE, Davenport KW,
Jaissle J, Frey KG, Koroleva GI, Bruce DC, Coyne SR, Broomall SM, Li PE,
Teshima H, Gibbons HS, Palacios GF, Rosenzweig CN, Redden CL, Xu Y,
Minogue TD, Chain PS. 2015. Complete genome sequences for 59
Burkholderia isolates, both pathogenic and near neighbor. Genome
Announc 3:e00159-15. https://doi.org/10.1128/genomeA.00159-15.
36. Delcher AL, Salzberg SL, Phillippy AM. 2003. Using MUMmer to identify
similar regions in large sequence sets. Curr Protoc Bioinformatics Chap-
ter 10:Unit 10.13.
37. Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis
and post-analysis of large phylogenies. Bioinformatics 30:1312–1313.
https://doi.org/10.1093/bioinformatics/btu033.
38. Kim M, Oh HS, Park SC, Chun J. 2014. Towards a taxonomic coherence
between average nucleotide identity and 16S rRNA gene sequence
similarity for species demarcation of prokaryotes. Int J Syst Evol Micro-
biol 64:346 –351. https://doi.org/10.1099/ijs.0.059774-0.
39. Konstantinidis KT, Tiedje JM. 2005. Genomic insights that advance the
species definition for prokaryotes. Proc Natl Acad Sci U S A 102:
2567–2572. https://doi.org/10.1073/pnas.0409727102.
40. Meier-Kolthoff JP, Auch AF, Klenk HP, Goker M. 2013. Genome sequence-
based species delimitation with confidence intervals and improved
distance functions. BMC Bioinformatics 14:60. https://doi.org/10.1186/
1471-2105-14-60.
41. Richter M, Rossello-Mora R. 2009. Shifting the genomic gold standard for
the prokaryotic species definition. Proc Natl Acad Sci U S A 106:
19126 –19131. https://doi.org/10.1073/pnas.0906412106.
Tuanyok et al. Applied and Environmental Microbiology
March 2017 Volume 83 Issue 5 e02802-16 aem.asm.org 10
